Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Hypercalcemia of Malignancy|Colon Cancer|Endocrine Cancer|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Lymphoma|Metastatic Cancer|Multiple Myeloma|Parathyroid Neoplasms|Renal Cancer|Thyroid Cancer|Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Non-Small Cell Lung Cancer
Interventions: DRUG: denosumab
Sponsor: Amgen